Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding
Clinical trial NCT04461639 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04461639
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-14
- Primary completion
- 2027-03-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.